Mainz Biomed is conducting an offering, with Maxim Group acting as the sole placement agent, filed with the SEC.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mainz Biomed is conducting an offering, with Maxim Group acting as the sole placement agent, filed with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Maxim Integrated
American company that designs, manufactures, and sells analog and mixed-signal integrated circuits
Nothing else this week.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
Coverage
Newest first; wire copies grouped- GlobeNewswireMainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants BERKELEY, Calif. and MAINZ, Germany, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ